Matsumoto Y
Center of Rheumatic Diseases, Toyokawa City Hospital.
Nihon Rinsho. 1999 Feb;57(2):364-9.
Fibromyalgia syndrome (FMS) is recognizable syndrome characterized by chronic, diffuse pain, an absence of inflammatory or structural muscloskeletal abnormalities, and a range of symptoms that include fatigue, and sleep and mood disturbances. Physical examination and laboratory testing are unrevealing, except for the presence of pain on palpation of characteristic soft-tissue sites, the tender points. Despite the recognition of FMS by the World Health Organization, it remains a controversial condition and its existence as a distinct entity remains uncertain. However, the concept of FMS is a useful one, allowing many investigations to be avoided and appropriate advice on treatment to be given. FMS may overlap with symptoms of, and the patient further impaired by, anxiety and depression. The term FMS dose not imply causation and merely describes the most common symptoms. Many patients with chronic fatigue syndrome(CFS) fulfill the criteria of FMS and represent one end of a spectrum of presentation. Evidence for triggering viral infection and the lower level of serum acylcarnitine, observed in CFS patients, is lacking in the majority of patients with FMS. These findings are suggestive to be distinctively another disorders between FMS and CFS.
纤维肌痛综合征(FMS)是一种可识别的综合征,其特征为慢性、弥漫性疼痛,不存在炎症性或结构性肌肉骨骼异常,以及一系列症状,包括疲劳、睡眠和情绪障碍。体格检查和实验室检查无异常发现,但在触诊特征性软组织部位(即压痛点)时会出现疼痛。尽管世界卫生组织已认可纤维肌痛综合征,但它仍然是一个有争议的病症,其作为一个独立实体的存在仍不确定。然而,纤维肌痛综合征的概念是有用的,可避免许多检查并给出适当的治疗建议。纤维肌痛综合征可能与焦虑和抑郁的症状重叠,使患者病情进一步恶化。纤维肌痛综合征这个术语并不意味着因果关系,仅仅描述了最常见的症状。许多慢性疲劳综合征(CFS)患者符合纤维肌痛综合征的标准,代表了临床表现范围的一端。在大多数纤维肌痛综合征患者中,缺乏在慢性疲劳综合征患者中观察到的触发病毒感染的证据以及血清酰基肉碱水平较低的情况。这些发现表明纤维肌痛综合征和慢性疲劳综合征明显是两种不同的疾病。